Abel Hall LLC’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $569K | Buy |
14,830
+294
| +2% | +$11.3K | 0.26% | 64 |
|
|
2025
Q1 | $563K | Buy |
14,536
+1,763
| +14% | +$68.3K | 0.34% | 46 |
|
|
2024
Q4 | $432K | Sell |
12,773
-672
| -5% | -$22.7K | 0.28% | 59 |
|
|
2024
Q3 | $550K | Buy |
13,445
+126
| +0.9% | +$5.15K | 0.36% | 41 |
|
|
2024
Q2 | $513K | Buy |
13,319
+163
| +1% | +$6.28K | 0.36% | 41 |
|
|
2024
Q1 | $564K | Buy |
13,156
+107
| +0.8% | +$4.59K | 0.42% | 36 |
|
|
2023
Q4 | $484K | Buy |
+13,049
| New | +$484K | 0.41% | 41 |
|